Back to top
Fidelity Advisor Biotechnology Cl C: (MF: FBTCX)
(NASDAQ Mutual Funds) As of May 16, 2024 08:00 PM ET
$23.02 USD
-0.04 (-0.17%)
Zacks MF Rank
2-Buy of 5 2
Latest Performance as of Apr 30, 2024
| Total Return %* | Percentile Rank Objective | |
|---|---|---|
| YTD | 2.79 | 61 |
| 3 months | -1.29 | 81 |
| 6 months | 27.75 | 9 |
| 1 Year | 15.10 | 11 |
| 3 Year | 0.41 | 55 |
| 5 Year | 8.14 | 73 |
| 10 Year | 8.03 | 74 |
* Annual for three years and beyond.
| Bull Market (9/02 - 10/07) | 95.55 |
| Bear Market (10/07 - 2/09) | -26.80 |
| Bull Market (2/09 - 3/21) | 699.21 |
Load Adjusted Returns as of Apr 30, 2024
| 1 Year | 29.23 |
| 5 Year | 9.27 |
| 10 Year | 8.40 |
| Since Inception | 6.80 |
Quarterly Return
| 1st Qtr. | 2nd Qtr. | 3rd Qtr. | 4th Qtr. | |
|---|---|---|---|---|
| 2024 | 12.93 | NA | NA | NA |
| 2023 | -4.95 | 3.92 | -5.07 | 17.16 |
| 2022 | -8.45 | -14.17 | 9.03 | 6.64 |
| 2021 | -3.75 | 1.59 | 1.04 | -3.13 |
| 2020 | -11.51 | 30.04 | -0.59 | 14.66 |
| 2019 | 13.96 | -1.86 | -8.58 | 22.06 |
Annual Return
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| % Total Return | 2.79 | 9.86 | -8.63 | -4.29 | 31.15 | 24.78 | -4.45 | 24.81 | -24.14 | 10.22 | 33.34 |
| % Total Return Rel to Index | -3.25 | -16.38 | 9.56 | -32.97 | 12.75 | -6.70 | -0.06 | 3.01 | -36.07 | 8.83 | 19.70 |
| % Total Return Rel to Peer | 0.77 | 4.09 | 0.77 | -12.98 | 9.88 | -1.90 | -4.57 | 2.69 | -13.36 | 2.79 | 7.67 |
| % Perf Quintile vs Peer* | 0.00 | 1.00 | 2.00 | 5.00 | 2.00 | 4.00 | 5.00 | 2.00 | 5.00 | 2.00 | 2.00 |
| % Dividends | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| % Yield | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capital Gains ($) | 0.00 | 0.00 | 0.00 | 5.24 | 2.73 | 1.85 | 0.59 | 0.00 | 0.00 | 1.31 | 0.60 |
| Expense Ratio | 1.76 | 1.76 | 1.74 | 1.75 | 1.76 | 1.77 | 1.80 | 1.79 | 1.79 | 1.79 | 1.83 |
* 1 = Top 20%, 5 = Bottom 20%